Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Cardiol Therapeutics Inc. (CRDL) vs Siga Technologies Inc. (SIGA)

Cardiol Therapeutics Inc. and Siga Technologies Inc. are both Drug Manufacturers Specialty & Generic companies. Siga Technologies Inc. is the larger, with a market value of $233.5M against $202.1M — 1.2× the size. Cardiol Therapeutics Inc. has the higher net margin (0.00% vs −5.19%) and the higher return on invested capital (0.00% vs −14.6%). Across the 15 metrics below, Siga Technologies Inc. leads on 9 and Cardiol Therapeutics Inc. on 6.

Valuation

Metric CRDL SIGA Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S n/m 4.61 2.25
P/B 11.32 1.50 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales n/m 2.45 2.56
Earnings yield (14.62%) (1.16%) (2.99%)
Free cash flow yield (8.77%) (8.29%) 0.00%

Profitability

Metric CRDL SIGA Drug Manufacturers Specialty & Generic median
Gross margin 0.00% 54.35% 53.94%
Operating margin 0.00% (20.76%) 0.00%
Net margin 0.00% (5.19%) 0.00%
Free cash flow margin 0.00% (37.58%) 0.00%
Return on equity (171.13%) (1.49%) (0.40%)
Return on assets (124.40%) (1.36%) (3.32%)
Return on invested capital 0.00% (14.59%) 0.00%

Growth

Metric CRDL SIGA Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (70.13%) 10.01%
EPS growth (last fiscal year) 24.32% (60.98%) —
Revenue growth, 5-year CAGR — (5.42%) 6.74%
Net income growth, 5-year CAGR 0.00% (16.20%) 0.00%

Health

Metric CRDL SIGA Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.00 0.05
Current ratio 5.55 21.72 2.31
Net debt to EBITDA 0.62 (6.39) 0.85

Dividend

Metric CRDL SIGA Drug Manufacturers Specialty & Generic median
Dividend yield — 0.00% 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric CRDL SIGA Drug Manufacturers Specialty & Generic median
Market cap 202.10m 233.51m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack